Abstract
Background Tuberculosis meningitis (TBM) is the most severe form of extrapulmonary tuberculosis with a high rate of morbidity and mortality. Treatments for TBM include conventional therapy alone as well as adjunctive use of steroidal therapy.
Methods A comprehensive search of electronic databases such as PubMed, Cochrane, and Scopus was conducted from inception to April 2024 to retrieve all randomized controlled trials (RCTs) that compared steroidal therapy plus conventional antituberculosis therapy with antituberculosis therapy alone for patients of TBM. Meta-analysis was performed using Review Manager 5.4. Dichotomous outcomes were compared using risk ratio (RR).
Results There was a statistically significant decrease in risk of mortality in the Steroid group compared to the control group (RR 0.84; 95% CI 0.75, 0.94; p-value < 0.05). However, there was no statistically significant difference in the risk of neurological deficit between the two groups. There was a statistically significant reduction in the risk of adverse events in the steroidal therapy group compared to the control group (RR 0.90; 95% CI 0.83, 0.98; p-value = 0.03). Similarly, there was a significant improvement in the clinical efficacy in the steroidal therapy group compared to the control (RR 1.16; 95% CI 1.02, 1.31; p-value = 0.02).
Conclusion Steroids in addition to antituberculosis therapy significantly reduce mortality and adverse events, while improving clinical outcomes in patients of TBM. There is a need for controlled studies with longer follow-up durations to improve the robustness of the results.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study received no funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Credit Author Statement: Ansa Naseem: Conceptualization, Methodology, Formal Analysis, Software, Data curation, Writing-original draft preparation; Muhammad Moiz Javed: Data curation, Methodology, Investigation, Writing - original draft; Malaika Rehmani: Data Curation, Methodology, Investigation, Validation, Visualization, Writing - original draft; Muhammad Haider Tariq: Data Curation, Writing - original draft, Visualization; Mahnoor Sikandar: Data Curation, Writing – Original draft; Usama Ejaz: Data Curation, Writing – Original draft; Muhammad Shahzaib Bajwa: Visualization, Investigation, Validation, Writing – review & editing; Tehseen Raza: Investigation, Visualization, Writing – review & editing; Muhammad Usman Khan: Investigation, Validation, Writing – review & editing; Ali Shehram: Investigation, Visualization, Writing – review & editing; Hammad Khan Supervision, Writing – original draft, review & editing; Muhammad Ayyan: Supervision, Writing – review & editing; Muhammad Luqman, MBBS4: Writing – review & editing.
Declaration of Interest: The authors have no conflict of interest
Funding: The authors received no funding.
Disclosure Statement: The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article.
Data availability statement: The data used in the study is available upon reasonable request to the author.
Data Availability
Data is available upon reasonable request to the authors.
